Fairmount Funds Management’s activist position in Apogee Therapeutics fell from above 5% to 0%, with its securities cancelled in the Merger and converted into $135.11 cash per share. The change matters because Fairmount no longer beneficially owns Apogee securities, while its voting agreement also ended when the transaction closed.

Key Highlights

  • Apogee’s merger converted each Fairmount-held common share and non-voting common share into $135.11 in cash.
  • Peter Evan Harwin exercised 42,208 vested director stock Options on August 7.
  • The voting agreement ended automatically when the merger was completed.

Apogee Therapeutics, Inc. (NASDAQ: APGE) no longer has Fairmount Funds Management LLC as a beneficial owner after the activist investor’s stake fell from above 5% to 0.0%. Fairmount and the associated reporting persons held 0.00 shares following the change. The position reached zero when Apogee’s merger was consummated on September 3, 2026.

Merger Converts Apogee Holdings

Each share of Apogee common stock and non-voting common stock held by the reporting persons immediately before the merger was cancelled and exchanged for $135.11 in cash per share, without interest. Stock options held by the reporting persons were also cancelled and converted into the excess of $135.11 over each option’s exercise price. The transaction left Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P. Peter Evan Harwin and Tomas Kiselak with no beneficial ownership of Apogee securities.

Fairmount Position Reaches Zero

Peter Evan Harwin exercised 42,208 vested director stock options for 42,208 Apogee common shares on August 7, 2026. Under his arrangement with Fairmount Funds Management LLC, any net cash or stock received from those options was to be transferred for the benefit of a Fairmount fund.

Voting Agreement Terminates

The merger automatically ended the voting agreement, which no longer has force or effect. Apogee’s directors, including Kiselak, resigned from the board immediately before the merger became effective.